Merck KGaA (LON:0O14)

London flag London · Delayed Price · Currency is GBP · Price in EUR
128.75
+0.75 (0.59%)
At close: Jan 9, 2026
-10.45%
Market Cap48.40B
Revenue (ttm)18.57B
Net Income (ttm)2.58B
Shares Outn/a
EPS (ttm)5.93
PE Ratio18.76
Forward PE15.34
Dividend1.87 (1.54%)
Ex-Dividend DateApr 28, 2025
Volume2,364
Average Volume22,770
Open128.30
Previous Close128.00
Day's Range127.70 - 129.35
52-Week Range100.90 - 154.65
Beta0.73
RSI74.97
Earnings DateMar 5, 2026

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables, devices, instruments, software, and services for research, production, and testing; process solutions consisting of filtration devices, chromatography... [Read more]

Industry Pharmaceutical Preparations
Founded 1668
Employees 59,020
Stock Exchange London Stock Exchange
Ticker Symbol 0O14
Full Company Profile

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.